Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SERPINA6 | P08185 | 4/20 | 0.65 |
| ▸ | SHBG | P04278 | 4/20 | 0.65 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.65 |
| ▸ | THRB | P10828 | 1/20 | 0.65 |
| ▸ | AR | P10275 | 5/20 | 0.58 |
| ▸ | PGR | P06401 | 3/20 | 0.55 |
| ▸ | CYP19A1 | P11511 | 7/20 | 0.46 |
| ▸ | PDK1 | Q15118 | 1/20 | 0.46 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.46 |
| ▸ | PDK3 | Q15120 | 1/20 | 0.46 |
| ▸ | PDK4 | Q16654 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 3/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.45 |
| ▸ | NR3C1 | P04150 | 2/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.45 |
| ▸ | TSHR | P16473 | 2/20 | 0.45 |
| ▸ | SNCA | P37840 | 2/20 | 0.45 |
| ▸ | CACNA1C | Q13936 | 2/20 | 0.45 |
| ▸ | CYP51A1 | Q16850 | 2/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21405873 | 1.00 | SERPINA6 (0.65) | SERPINA6SHBGSLC22A1ALDH1A1THRB | |
| SCHEMBL24102420 | 1.00 | SERPINA6 (0.65) | SERPINA6SHBGSLC22A1ALDH1A1THRB | |
| SCHEMBL24102505 | 1.00 | SERPINA6 (0.65) | SERPINA6SHBGSLC22A1ALDH1A1THRB | |
| SCHEMBL24102619 | 1.00 | SERPINA6 (0.65) | SERPINA6SHBGSLC22A1ALDH1A1THRB | |
| SCHEMBL6241504 | 0.89 | SERPINA6 (0.67) | SERPINA6SHBGSLC22A1ALDH1A1THRB | |
| SCHEMBL25863907 | 0.88 | PGR (0.54) | SERPINA6SHBGSLC22A1ALDH1A1THRB | |
| SCHEMBL25863839 | 0.88 | PGR (0.54) | SERPINA6SHBGSLC22A1ALDH1A1THRB | |
| SCHEMBL25863497 | 0.88 | PGR (0.54) | SERPINA6SHBGSLC22A1ALDH1A1THRB | |
| SCHEMBL25863928 | 0.88 | PGR (0.54) | SERPINA6SHBGSLC22A1ALDH1A1THRB | |
| SCHEMBL5501842 | 0.87 | SERPINA6 (0.64) | SERPINA6SHBGSLC22A1ALDH1A1THRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240238310-A1 | MODULATION OF SEX STEROID HORMONE PRODUCTION AND ACTIVITY FOR TREATING AND PREVENTING HERNIAS | NORTHWESTERN UNIVERSITY | 2024-07-18 | — | — | US | disclosed |
| US-20230227492-A1 | MONOMERIC AND OLIGOMERIC COMPOUND EMBODIMENTS AS CONTRACEPTIVES AND THERAPIES AND METHODS OF MAKING AND USING THE SAME | THE USA AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2023-07-20 | — | — | US | disclosed |
| US-20230227492-A1 | MONOMERIC AND OLIGOMERIC COMPOUND EMBODIMENTS AS CONTRACEPTIVES AND THERAPIES AND METHODS OF MAKING AND USING THE SAME | THE USA AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2023-07-20 | — | — | US | disclosed |
| EP-4164743-A2 | MONOMERIC AND OLIGOMERIC COMPOUND EMBODIMENTS AS CONTRACEPTIVES AND THERAPIES AND METHODS OF MAKING AND USING THE SAME | The United States of America, as represented by The Secretary, Department of Health and Human Services (US) | 2023-04-19 | — | — | EP | disclosed |
| WO-2021252761-A2 | MONOMERIC AND OLIGOMERIC COMPOUND EMBODIMENTS AS CONTRACEPTIVES AND THERAPIES AND METHODS OF MAKING AND USING THE SAME | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2021-12-16 | — | — | WO | disclosed |
| WO-2021252761-A2 | MONOMERIC AND OLIGOMERIC COMPOUND EMBODIMENTS AS CONTRACEPTIVES AND THERAPIES AND METHODS OF MAKING AND USING THE SAME | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2021-12-16 | — | — | WO | disclosed |
| US-20210283144-A1 | MODULATION OF SEX STEROID HORMONE PRODUCTION AND ACTIVITY FOR TREATING AND PREVENTING HERNIAS | NORTHWESTERN UNIVERSITY | 2021-09-16 | — | — | US | disclosed |
| US-20190298646-A1 | COMPOSITIONS AND METHODS FOR TREATING INFLAMMATORY CONDITIONS | INITIUM INNOVATIONS, INC. | 2019-10-03 | — | — | US | disclosed |
| US-7820642-B2 | Nandrolone 17β-carbonates | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2010-10-26 | — | — | US | disclosed |
| EP-1846434-B1 | NANDROLONE 17ß-CARBONATES | US GOV HEALTH & HUMAN SERV (US) | 2009-03-25 | — | — | EP | disclosed |
| US-20080167283-A1 | Nandrolone 17 Beta-Carbonates | GOVERNMENT OF THE UNITED STATES OF AMERICA, REPRE- SENTED BY THE SECRETARY, DEPA (US) | 2008-07-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230227492-A1 | MONOMERIC AND OLIGOMERIC COMPOUND EMBODIMENTS AS CONTRACEPTIVES AND THERAPIES AND METHODS OF MAKING AND USING THE SAME | SHBG, CYP19A1, GNRHR | SERPINA6 55/4885SHBG 1/4885SLC22A1 4683/4885 |
| US-20080167283-A1 | Nandrolone 17 Beta-Carbonates | HSD3B1, HSD3B2, HSD17B7 | SERPINA6 369/4885SHBG 22/4885SLC22A1 706/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.